Newsfile Corp
09 Jul 2026, 14:47 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Phreesia announced significantly reduced revenue growth projections for fiscal year 2027 due to worsening visibility and weaker pharmaceutical marketing commitments in its Network Solutions segment. — Downward revisions of future revenue guidance are primary drivers of stock price declines and signal systemic weakness in a core business segment.
-0.80A federal securities class action lawsuit has been filed against Phreesia alleging that executives made false or misleading statements regarding the company's growth potential and AccessOne acquisition. — Securities litigation creates potential for significant financial settlements and introduces governance risk and reputational damage.
-0.50Phreesia's common stock price fell approximately 27% from $11.41 to $8.38 following the March 30, 2026, guidance announcement. — This represents a realized loss of market capitalization and confirms a negative shift in investor sentiment.
-0.30Continue reading
6 related stories
Search tags
Which stocks this story touches
The company is facing a federal securities class action lawsuit alleging fraud, misleading statements, and a significant drop in stock price due to reduced revenue projections.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
3h ago
